Gilead Sciences (GILD) FY2021 results: revenue $27.3 billion, up 10.6% on the year
Gilead Sciences, Inc. (GILD) reported revenue of $27.3 billion for fiscal 2021, the year ended 31 December 2021, up 10.6% on the year before. Net income was $6.2 billion, up 4961.0%, and diluted earnings per share $4.93. The figures are the company's own, from the 10-K it filed with the SEC on 23 February 2022.
Revenue
$27.3 billion
+10.6% on the year
FY2014FY2021
Operating margin
36.3%
16.5% a year earlier
FY2014FY2021
Net income
$6.2 billion
+4,961.0% on the year
FY2014FY2021
Diluted EPS
$4.93
+4,830.0% on the year
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
11,384
8,168
9,144
+39.4%
Capital expenditure
579
650
825
-10.9%
Free cash flow
10,805
7,518
8,319
+43.7%
Free cash flow margin
39.6%
30.5%
37.1%
Cash from investing
-3,131
-14,615
-7,817
Cash from financing
-8,877
770
-7,634
Depreciation and amortisation
2,029
1,488
n/a
+36.4%
Share-based compensation
635
643
636
-1.2%
Buybacks
546
1,583
1,749
-65.5%
Dividends paid
3,605
3,449
3,222
+4.5%
Dividend per share
$2.84
$2.72
$2.52
+4.4%
Diluted shares, weighted
1,262m
1,263m
1,277m
-0.1%
Shares outstanding at period end
1,254m
1,254m
1,266m
0.0%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
21,069
18,202
22,525
+15.8%
Non-controlling interest
-5.0
19.0
125
Debt
26,695
31,402
24,593
-15.0%
Operating lease liabilities
489
608
626
-19.6%
Other liabilities
19,704
18,176
13,758
+8.4%
Total liabilities and equity
67,952
68,407
61,627
-0.7%
Fixed assets
5,121
4,967
4,502
+3.1%
Goodwill
8,332
8,108
4,117
+2.8%
Intangible assets
33,455
33,126
13,786
+1.0%
Investments
2,491
1,913
14,209
+30.2%
Cash and equivalents
5,338
5,997
11,631
-11.0%
Receivables
4,493
4,892
3,582
-8.2%
Inventory
1,618
1,683
922
-3.9%
Other assets
7,104
7,721
8,878
-8.0%
Total assets
67,952
68,407
61,627
-0.7%
10-K for the year ended 31 December 2021, filed 23 February 2022: the filing.